AT&TSample data
Benefits & Procurement · Fee Structure

Fee Structure & Value-Based Terms

How the program is priced, what portion is at risk, and how fees tie to measured outcomes.

Sample dataObserved
Total fee per member / year
$5,400
all-in program cost
Observed
Guaranteed portion
$8,100,000
75% of total
Observed
At-risk portion
$2,700,000
25% tied to outcomes
Observed
Bonus eligible
Yes
$60K potential
Observed

Fee composition by component

Observed
100%
66.7%
11.1%
GLP-1 medication$5,400/ mo
Clinical platform & providers$3,600/ mo
Care navigation & coaching$600/ mo

At-risk outcome terms

3/4 met
6-month persistence rate
Target 75 · Actual 79Met
Weight: 40% of at-risk pool
Weight loss ≥5% (cohort)
Target 55 · Actual 61Met
Weight: 30% of at-risk pool
Outcome data capture rate
Target 80 · Actual 76Below
Weight: 20% of at-risk pool
Member satisfaction (CSAT)
Target 85 · Actual 88Met
Weight: 10% of at-risk pool
Bonus eligible

Persistence > 78% and weight loss ≥5% > 60%

$60K potential bonus

Fee & value comparison across scenarios

Modeled
MetricConservativeBaseOptimistic
Enrollment rate1.5%2%3%
Productivity reduction18%25%32%
Fee per member$5,400$5,400$5,400
At-risk percentage30%25%20%
Eligible population30,00030,00030,000
Enrolled members1,5002,0003,000
Total annual fee$8.10M$10.80M$16.20M
Fee at risk$2.43M$2.70M$3.24M
Cost avoidance$3.33M$5.25M$8.77M
Productivity value$5.22M$6.16M$8.34M
Net economic impact$3.02M$4.02M$6.03M

How value-based pricing works

1. Guaranteed base

75% of the per-member fee ($8,100,000) is guaranteed regardless of outcomes. Covers medication, platform, and care team costs.

2. At-risk portion

25% ($2,700,000) is at risk, tied to persistence, weight loss, data capture, and satisfaction targets. Released only when targets are met.

3. Performance bonus

Up to $60K in bonus fees when persistence exceeds 78% and weight loss ≥5% exceeds 60% of cohort.

Employee Privacy Protected by Design

Employer reporting is designed to present aggregate workforce and health-program insights without exposing individual clinical records. Small-group reporting restrictions help reduce the risk of employee identification.

Sample dataPrivacy-restricted reporting

Aggregated information is not described as HIPAA-de-identified unless applicable de-identification requirements have been satisfied and verified.

Sample Data — Demonstration Only. Fictional data, not actual patient records or validated outcomes.